1059 related articles for article (PubMed ID: 15535106)
21. Clinical use of the beta1-selective adrenoceptor blocker metoprolol in hypertension, angina pectoris and arrhythmias.
Ann Clin Res; 1981; 13 Suppl 30():1-72. PubMed ID: 6117243
[No Abstract] [Full Text] [Related]
22. Beta blockers: the extended family.
Hager WD; Messineo FC; Katz AM
Adv Intern Med; 1984; 30():201-29. PubMed ID: 6152107
[TBL] [Abstract][Full Text] [Related]
23. beta-Blocker therapy for congestive heart failure: clinical considerations.
Kamath SA; Yancy CW
Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):12-20. PubMed ID: 19667706
[TBL] [Abstract][Full Text] [Related]
24. [Choice of beta-blocking agents].
Iisalo E
Duodecim; 1986; 102(22):1642-50. PubMed ID: 2879719
[No Abstract] [Full Text] [Related]
25. [Beta-blockaders and cardiovascular treatment: facts and theories. Part II. Therapeutic indications: ischemic heart disease and arrhythmia; limitations; conclusions].
Motolese M
G Ital Cardiol; 1978; 8(3):333-49. PubMed ID: 25219
[No Abstract] [Full Text] [Related]
26. [Clinical pharmacology and indications for treatment with calcium antagonists].
Bölter C
Z Arztl Fortbild (Jena); 1984; 78(1):1-4. PubMed ID: 6143456
[No Abstract] [Full Text] [Related]
27. Beta-adrenergic blocking drugs.
Gerber JG; Nies AS
Annu Rev Med; 1985; 36():145-64. PubMed ID: 2581498
[TBL] [Abstract][Full Text] [Related]
28. [Principal pharmacological properties of different beta-blockers, possibilities and new perspectives of their uses].
Antelava N; Antelava A; Pachkoria K; Pirtskhalaishvili N
Georgian Med News; 2006 Dec; (141):38-46. PubMed ID: 17261885
[TBL] [Abstract][Full Text] [Related]
29. [Drug treatment following an infarction].
Lasserre B; Périat M
Rev Med Suisse Romande; 1994 Aug; 114(8):677-81. PubMed ID: 7939090
[No Abstract] [Full Text] [Related]
30. The role of beta-blockers as a cornerstone of cardiovascular therapy.
Hollenberg NK
Am J Hypertens; 2005 Dec; 18(12 Pt 2):165S-168S. PubMed ID: 16373194
[TBL] [Abstract][Full Text] [Related]
31. [How many beta-receptor blockers does the physician need?].
Palm D
Klin Wochenschr; 1987 Mar; 65(6):289-95. PubMed ID: 2884346
[No Abstract] [Full Text] [Related]
32. [15 years of therapy with beta-receptor blockers. Tendency for differentiation].
Kersting F; Kasper W; Meinertz T
Med Klin; 1979 Aug; 74(32-33):1179-88. PubMed ID: 38385
[No Abstract] [Full Text] [Related]
33. [Present trends and controversies in the use of beta-blockers in cardiovascular diseases].
Spoladore R; Fragasso G; Montanaro C; Maranta F; Torlasco C; Gerosa S; Margonato A
Recenti Prog Med; 2010 Nov; 101(11):429-41. PubMed ID: 21197763
[TBL] [Abstract][Full Text] [Related]
34. [Treatment with beta receptor blockers].
Lydtin H
Dtsch Med Wochenschr; 1969 Dec; 94(49):2560-2. PubMed ID: 4391114
[No Abstract] [Full Text] [Related]
35. Are we misunderstanding beta-blockers.
Cruickshank JM
Int J Cardiol; 2007 Aug; 120(1):10-27. PubMed ID: 17433471
[TBL] [Abstract][Full Text] [Related]
36. [Pharmacology and clinical use of adrenergic beta-blocking agents].
Colace F
Policlinico Prat; 1970 May; 77(20):645-56. PubMed ID: 4393034
[No Abstract] [Full Text] [Related]
37. Cardioprotection with beta-blockers: myths, facts and Pascal's wager.
Messerli FH; Bangalore S; Yao SS; Steinberg JS
J Intern Med; 2009 Sep; 266(3):232-41. PubMed ID: 19702791
[TBL] [Abstract][Full Text] [Related]
38. Nebivolol: a third-generation beta-blocker for hypertension.
Cheng JW
Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
[TBL] [Abstract][Full Text] [Related]
39. [Clinical use of beta adrenergic inhibiting agents in cardiovascular therapeutics].
Scebat L
Therapeutique; 1968 Nov; 44(9):560-4. PubMed ID: 4396094
[No Abstract] [Full Text] [Related]
40. [Beta-blocker in secondary prevention of cardiovascular disease].
Sauer G
Z Kardiol; 2003 Jan; 92(1):24-30. PubMed ID: 12545298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
